{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:08:08Z","timestamp":1789985288304,"version":"4.0.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200886"],"award-info":[{"award-number":["82200886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118723","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T15:46:43Z","timestamp":1761925603000},"page":"118723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Relationship between hepatic lipid accumulation and type\u00a02 diabetes mellitus"],"prefix":"10.1016","volume":"193","author":[{"given":"Zhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118723_bib1","doi-asserted-by":"crossref","first-page":"51724","DOI":"10.12775\/QS.2024.22.51724","article-title":"The Association between Vitamin D deficiency and the prognosis of type 2 diabetes mellitus","volume":"22","author":"Dobrzeniecki","year":"2024","journal-title":"Qual. Sport"},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4093\/dmj.2023.0011","article-title":"Adipose tissue and metabolic health","volume":"47","author":"An","year":"2023","journal-title":"Diabetes Metab. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib3","doi-asserted-by":"crossref","first-page":"2266147","DOI":"10.1080\/21623945.2023.2266147","article-title":"Regulatory effects and mechanisms of exercise on activation of brown adipose tissue (BAT) and browning of white adipose tissue (WAT)","volume":"12","author":"Dong","year":"2023","journal-title":"Adipocyte"},{"key":"10.1016\/j.biopha.2025.118723_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molmet.2019.12.014","article-title":"Mechanisms of insulin resistance related to white, beige, and brown adipocytes","volume":"34","author":"Czech","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2025.118723_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.05.010","article-title":"Implications of hydrogen sulfide in liver pathophysiology: mechanistic insights and therapeutic potential","volume":"27","author":"Sun","year":"2021","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2025.118723_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101411","article-title":"URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice","volume":"55","author":"Tanaka","year":"2022","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","article-title":"Physiological and pathological roles of lipogenesis","volume":"5","author":"Jeon","year":"2023","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030390","article-title":"The role of hepatic fat accumulation in glucose and insulin homeostasis-dysregulation by the liver","volume":"10","author":"London","year":"2021","journal-title":"J. Clin. Med."},{"issue":"50","key":"10.1016\/j.biopha.2025.118723_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028303","article-title":"Danning tablets might improve glucose and lipid metabolism in asymptomatic T2MD patients after cholecystectomy: a cohort study","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine"},{"issue":"ement_1","key":"10.1016\/j.biopha.2025.118723_bib10","article-title":"1579-P: impact of adipose tissue insulin sensitivity on hepatic insulin sensitivity preservation in longitudinal observation of patients with NAFLD","volume":"72","author":"Shigiyama","year":"2023","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00125-019-4820-6","article-title":"Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat","volume":"62","author":"Bello","year":"2019","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.cmet.2020.08.001","article-title":"A membrane-bound diacylglycerol species induces PKC\u03f5-mediated hepatic insulin resistance","volume":"32","author":"Lyu","year":"2020","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2023.01.014","article-title":"Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue","volume":"78","author":"Falkevall","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2025.118723_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib16","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1152\/ajpendo.00620.2020","article-title":"100(th) anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism","volume":"320","author":"Carpentier","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/joim.13214","article-title":"Type 2 diabetes and remission: practical management guided by pathophysiology","volume":"289","author":"Taylor","year":"2021","journal-title":"J. Intern Med."},{"issue":"18","key":"10.1016\/j.biopha.2025.118723_bib18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review","volume":"23","author":"Cariou","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2025.118723_bib20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00535-018-1472-0","article-title":"Hepatic IRS1 and \u00df-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients","volume":"53","author":"Enooku","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib21","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0313","article-title":"An adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis","volume":"262","author":"Risi","year":"2024","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib22","article-title":"Modeling the effect of high calorie diet on the interplay between adipose tissue, inflammation, and diabetes","volume":"2019","author":"Prana","year":"2019","journal-title":"Comput. Math. Methods Med."},{"issue":"12","key":"10.1016\/j.biopha.2025.118723_bib23","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200291","article-title":"Adipose tissue in health and disease","volume":"10","author":"Harvey","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.biopha.2025.118723_bib24","article-title":"Exposing the causal effect of body mass index on the risk of type 2 diabetes mellitus: a mendelian randomization study","volume":"10","author":"Cheng","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2025.118723_bib25","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.2147\/IJGM.S341790","article-title":"Nonlinear relationship between AST-to-ALT ratio and the incidence of type 2 diabetes mellitus: a follow-up study","volume":"14","author":"Niu","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.biopha.2025.118723_bib26","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.2147\/DMSO.S337416","article-title":"Association between aspartate aminotransferase to alanine aminotransferase ratio and incidence of type 2 diabetes mellitus in the japanese population: a secondary analysis of a retrospective cohort study","volume":"14","author":"Chen","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"ement_1","key":"10.1016\/j.biopha.2025.118723_bib27","article-title":"1565-P: relationship between glycemic control, body weight, and nonalcoholic fatty liver disease in patients with type 1 diabetes","volume":"72","author":"DHAVER","year":"2023","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13612","article-title":"Liver fat as risk factor of hepatic and cardiometabolic diseases","volume":"24","author":"Demir","year":"2023","journal-title":"Obes. Rev."},{"key":"10.1016\/j.biopha.2025.118723_bib29","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/dc19-1892","article-title":"Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes","volume":"43","author":"Hartman","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab. J."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/10715762.2019.1635252","article-title":"Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation","volume":"53","author":"Malik","year":"2019","journal-title":"Free Radic. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdi.13756","article-title":"Non-alcoholic fatty liver disease and type\u20092 diabetes: an update","volume":"13","author":"Lee","year":"2022","journal-title":"J. Diabetes Invest."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-020-00097-1","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?","volume":"6","author":"Tomah","year":"2020","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4239\/wjd.v14.i7.1049","article-title":"Liver or kidney: Who has the oar in the gluconeogenesis boat and when?","volume":"14","author":"Sahoo","year":"2023","journal-title":"World J. Diabetes"},{"issue":"7800","key":"10.1016\/j.biopha.2025.118723_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biopha.2025.118723_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00467-20","article-title":"The nutrient and energy pathway requirements for surface motility of nonpathogenic and uropathogenic Escherichia coli","volume":"203","author":"Sudarshan","year":"2021","journal-title":"J. Bacteriol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib39","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00125-023-05889-5","article-title":"Upregulated TGF-\u03b21 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling","volume":"66","author":"Xiao","year":"2023","journal-title":"Diabetologia"},{"issue":"13","key":"10.1016\/j.biopha.2025.118723_bib40","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.7150\/ijbs.31781","article-title":"Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1\/PGC-1\u03b1 pathway in high-fat-diet-induced rats and insulin resistant cells","volume":"15","author":"Gu","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.biopha.2025.118723_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176286","article-title":"Fanconi-bickel syndrome: a review of the mechanisms that lead to dysglycaemia","volume":"21","author":"Sharari","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076085","article-title":"Relevance of sugar transport across the cell membrane","volume":"24","author":"Carb\u00f3","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11154-021-09652-2","article-title":"AKT ISOFORMS-AS160-GLUT4: the defining axis of insulin resistance","volume":"22","author":"Sharma","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14010012","article-title":"Lipid metabolism in metabolic-associated steatotic liver disease (MASLD)","volume":"14","author":"Syed-Abdul","year":"2023","journal-title":"Metabolites"},{"issue":"24","key":"10.1016\/j.biopha.2025.118723_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021109","article-title":"The role of SCAP\/SREBP as central regulators of lipid metabolism in hepatic steatosis","volume":"25","author":"Chandrasekaran","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072054","article-title":"Srebp-1c\/Fgf21\/Pgc-1\u03b1 axis regulated by leptin signaling in adipocytes-possible mechanism of caloric restriction-associated metabolic remodeling of white adipose tissue","volume":"12","author":"Kobayashi","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.biopha.2025.118723_bib48","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbadis.2009.08.015","article-title":"Enhancement in liver SREBP-1c\/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion","volume":"1792","author":"Pettinelli","year":"2009","journal-title":"Biochim Biophys. Acta"},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071778","article-title":"Recent progress on fructose metabolism-chrebp, fructolysis, and polyol pathway","volume":"15","author":"Iizuka","year":"2023","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2025.118723_bib50","article-title":"Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma","volume":"5","author":"Talamantes","year":"2023","journal-title":"JHEP Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3803\/EnM.2020.850","article-title":"Mechanism of lipid accumulation through PAR2 signaling in diabetic male mice","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118723_bib52","doi-asserted-by":"crossref","DOI":"10.37349\/emed.2020.00019","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin","volume":"1","author":"Acierno","year":"2020","journal-title":"Explor. Med."},{"key":"10.1016\/j.biopha.2025.118723_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.691556","article-title":"Varied relationship of lipid and lipoprotein profiles to liver fat content in phenotypes of metabolic associated fatty liver disease","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118723_bib54","doi-asserted-by":"crossref","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","article-title":"The crucial role and mechanism of insulin resistance in metabolic disease","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib55","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41418-022-00974-5","article-title":"Activation of Drp1 promotes fatty acids-induced metabolic reprograming to potentiate Wnt signaling in colon cancer","volume":"29","author":"Xiong","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11010091","article-title":"Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease","volume":"11","author":"Ma","year":"2021","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042357","article-title":"Role of mitochondrial pathways in cell apoptosis during He-patic ischemia\/reperfusion injury","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118723_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094459","article-title":"Mitochondrial mutations and genetic factors determining NAFLD risk","volume":"22","author":"Dabravolski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165838","article-title":"Mitochondrial dysfunction in metabolic syndrome","volume":"1866","author":"Prasun","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"18","key":"10.1016\/j.biopha.2025.118723_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813782","article-title":"Mitochondrial dynamics and insulin secretion","volume":"24","author":"Kabra","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","article-title":"Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease","volume":"11","author":"Legaki","year":"2022","journal-title":"Curr. Obes. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib62","article-title":"Mitochondrial dysfunction: a promising therapeutic target for liver diseases","volume":"11","author":"Chen","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.biopha.2025.118723_bib63","article-title":"PGC-1\u03b1-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib65","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41598-023-28395-5","article-title":"Sulforaphane ameliorates bisphenol A-induced hepatic lipid accumulation by inhibiting endoplasmic reticulum stress","volume":"13","author":"Hong","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib66","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/s41598-023-42136-8","article-title":"EP300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12192-020-01134-9","article-title":"Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain","volume":"25","author":"Dores-Silva","year":"2020","journal-title":"Cell Stress Chaperon."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib68","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12164","article-title":"Endoplasmic reticulum stress promotes epithelial\u2011mesenchymal transition via the PERK signaling pathway in paraquat\u2011induced pulmonary fibrosis","volume":"24","author":"Meng","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070791","article-title":"Roles of XBP1s in transcriptional regulation of target genes","volume":"9","author":"Park","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118723_bib70","article-title":"Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118723_bib71","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16398","article-title":"Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease","volume":"11","author":"Na","year":"2023","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252607","article-title":"Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes","volume":"16","author":"Dhounchak","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13298","article-title":"Oxygenation of adipose tissue: a human perspective","volume":"228","author":"Lempesis","year":"2020","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40580-023-00377-3","article-title":"Functional photoacoustic imaging: from nano- and micro- to macro-scale","volume":"10","author":"Park","year":"2023","journal-title":"Nano Converg."},{"key":"10.1016\/j.biopha.2025.118723_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746151","article-title":"Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites","volume":"12","author":"Russo","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118723_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220577","article-title":"Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages","volume":"14","author":"Morey","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2025.118723_bib77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trsl.2021.05.006","article-title":"Macrophage polarization and diabetic wound healing","volume":"236","author":"Louiselle","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2025.118723_bib78","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fendo.2020.00062","article-title":"Mechanisms of macrophage polarization in insulin signaling and sensitivity","volume":"11","author":"Orliaguet","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib79","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting Janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharm. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041774","article-title":"IL-6 reduces mitochondrial replication, and IL-6 receptors reduce chronic inflammation in NAFLD and type 2 diabetes","volume":"22","author":"Skuratovskaia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib81","article-title":"Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease","volume":"5","author":"Wang","year":"2023","journal-title":"JHEP Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib82","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2025.118723_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174884","article-title":"HM-chromanone attenuates TNF-\u03b1-mediated inflammation and insulin resistance by controlling JNK activation and NF-\u03baB pathway in 3T3-L1 adipocytes","volume":"921","author":"Park","year":"2022","journal-title":"Eur. J. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101545","article-title":"Coffee bioactive N-methylpyridinium attenuates tumor necrosis factor (TNF)-\u03b1-mediated insulin resistance and inflammation in human adipocytes","volume":"11","author":"Quarta","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118723_bib85","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fendo.2020.00161","article-title":"General adaptation in critical illness: glucocorticoid receptor-alpha master regulator of homeostatic corrections","volume":"11","author":"Meduri","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/oby.22674","article-title":"Adipose tissue macrophage phenotypes and characteristics: the key to insulin resistance in obesity and metabolic disorders","volume":"28","author":"Ni","year":"2020","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib87","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/s41467-023-37831-z","article-title":"Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance","volume":"14","author":"Caratti","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041219","article-title":"Multifaceted physiological roles of adiponectin in inflammation and diseases","volume":"21","author":"Choi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib89","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s42255-019-0041-z","article-title":"Metabolic messengers: adiponectin","volume":"1","author":"Straub","year":"2019","journal-title":"Nat. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2025.118723_bib90","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4239\/wjd.v15.i8.1753","article-title":"Functional analysis of the novel mitochondrial tRNA(Trp) and tRNA(Ser(AGY)) variants associated with type 2 diabetes mellitus","volume":"15","author":"Ding","year":"2024","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2025.118723_bib91","first-page":"149","article-title":"Identification of a novel mitochondrial tRNA mutation in chinese family with type 2 diabetes mellitus","volume":"17","author":"Li","year":"2024","journal-title":"Pharmgenomics Pers. Med."},{"key":"10.1016\/j.biopha.2025.118723_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.974083","article-title":"UPR(mt) and coordinated UPR(ER) in type 2 diabetes","volume":"10","author":"Kang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118723_bib93","doi-asserted-by":"crossref","first-page":"1158648","DOI":"10.3389\/fimmu.2023.1158648","article-title":"Comprehensive analysis of endoplasmic reticulum stress-associated genes signature of ulcerative colitis","volume":"14","author":"Deng","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118723_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2024.100184","article-title":"Endoplasmic reticulum stress in pancreatic \u03b2-cell dysfunction: the potential therapeutic role of dietary flavonoids","volume":"6","author":"Mbara","year":"2024","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"8","key":"10.1016\/j.biopha.2025.118723_bib95","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1007\/s10571-023-01399-5","article-title":"Neuroprotective effect of hydrogen sulfide subchronic treatment against TBI-induced ferroptosis and cognitive deficits mediated through wnt signaling pathway","volume":"43","author":"Chen","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41420-022-00982-x","article-title":"Targeting lncRNAs in programmed cell death as a therapeutic strategy for non-small cell lung cancer","volume":"8","author":"Luo","year":"2022","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib97","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib98","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.7150\/ijbs.86465","article-title":"The role of STAT3\/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD","volume":"20","author":"Jiang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118723_bib99","article-title":"Ferroptosis: a trigger of proinflammatory state progression to immunogenicity in necroinflammatory disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118723_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.879317","article-title":"Ferroptosis and tumor drug resistance: current status and major challenges","volume":"13","author":"Nie","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118723_bib101","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3390\/su12072866","article-title":"Hematite\/graphitic carbon nitride nanofilm for fenton and photocatalytic oxidation of methylene blue","volume":"12","author":"Lee","year":"2020","journal-title":"Sustainability"},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071493","article-title":"Anti-adipogenic activity of high-phenolic sorghum brans in pre-adipocytes","volume":"14","author":"Lee","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030950","article-title":"Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes","volume":"27","author":"Singh","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118723_bib104","doi-asserted-by":"crossref","first-page":"1187985","DOI":"10.3389\/fgene.2023.1187985","article-title":"Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies","volume":"14","author":"Li","year":"2023","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050804","article-title":"Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis","volume":"12","author":"Mortensen","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress","volume":"14","author":"Dludla","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2025.118723_bib107","doi-asserted-by":"crossref","first-page":"1329147","DOI":"10.3389\/fcell.2023.1329147","article-title":"Understanding the unique mechanism of ferroptosis: a promising therapeutic target","volume":"11","author":"Kong","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118723_bib108","doi-asserted-by":"crossref","first-page":"1102158","DOI":"10.3389\/fmolb.2022.1102158","article-title":"Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions","volume":"9","author":"Tan","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"18","key":"10.1016\/j.biopha.2025.118723_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189902","article-title":"Ferroptosis mechanisms involved in hippocampal-related diseases","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11061188","article-title":"Selenium and selenoproteins at the intersection of type 2 diabetes and thyroid pathophysiology","volume":"11","author":"Gorini","year":"2022","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040721","article-title":"A genotype-phenotype analysis of glutathione peroxidase 4 in human atrial myocardium and its association with postoperative atrial fibrillation","volume":"11","author":"Berdaweel","year":"2022","journal-title":"Antioxidants"},{"issue":"16","key":"10.1016\/j.biopha.2025.118723_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168838","article-title":"Ferroptosis-A shared mechanism for Parkinson's disease and type 2 diabetes","volume":"25","author":"Du\u021b\u0103","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118723_bib113","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1271\/kagakutoseibutsu.60.573","article-title":"Effects of Selenium and Vitamin E on Ferroptosis, a Form of Cell Death Associated with Iron-dependent Lipid Peroxidation\u9244\u4f9d\u5b58\u7684\u306a\u8102\u8cea\u9178\u5316\u3092\u4f34\u3046\u7d30\u80de\u6b7b\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u306b\u5bfe\u3059\u308b\u30bb\u30ec\u30f3\u30fb\u30d3\u30bf\u30df\u30f3E\u306e\u4f5c\u7528: Mechanism of Novel Programmed Cell Death \u201cFerroptosis\u201d\u65b0\u305f\u306a\u30d7\u30ed\u30b0\u30e9\u30e0\u7d30\u80de\u6b7b\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u306e\u30e1\u30ab\u30cb\u30ba\u30e0","volume":"60","author":"Arisawa","year":"2022","journal-title":"KAGAKU SEIBUTSU"},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s10020-023-00724-4","article-title":"Acid sphingomyelinase mediates ferroptosis induced by high glucose via autophagic degradation of GPX4 in type 2 diabetic osteoporosis","volume":"29","author":"Du","year":"2023","journal-title":"Mol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.31083\/j.fbl2702068","article-title":"Association of serum lipid peroxidation and glutathione peroxidase 4 levels with clinical outcomes and metabolic abnormalities among patients with gestational diabetes mellitus: a case-control study in the Chinese population","volume":"27","author":"Zhang","year":"2022","journal-title":"Front. Biosci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1036","article-title":"Identification of ferroptosis-related genes in type 2 diabetes mellitus based on machine learning","volume":"11","author":"Wang","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2025.118723_bib117","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1530\/EC-21-0316","article-title":"Serum ferritin as a risk factor for type 2 diabetes mellitus, regulated by liver transferrin receptor 2","volume":"10","author":"Zhang","year":"2021","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.biopha.2025.118723_bib118","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fphar.2024.1366852","article-title":"Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib119","first-page":"2233906","article-title":"Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases","volume":"2022","author":"Li","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2025.118723_bib120","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaa021","article-title":"FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations","volume":"2020","author":"Zhou","year":"2020","journal-title":"Database"},{"key":"10.1016\/j.biopha.2025.118723_bib121","first-page":"2023","article-title":"Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Oncol."},{"issue":"6586","key":"10.1016\/j.biopha.2025.118723_bib122","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118723_bib123","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fendo.2024.1344729","article-title":"Cuproptosis: potential new direction in diabetes research and treatment","volume":"15","author":"Qu","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118723_bib124","first-page":"2024","article-title":"Potential molecular and cellular mechanisms of the effects of cuproptosis-related genes in the cardiomyocytes of patients with diabetic heart failure: a bioinformatics analysis","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib125","article-title":"A review on glycemic control in type 2 diabetes mellitus by arm ergometer exercise","volume":"14","author":"Dhait","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib126","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","article-title":"Incretin hormones and type 2 diabetes","volume":"66","author":"Nauck","year":"2023","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib127","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.14496","article-title":"The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update","volume":"23","author":"Nauck","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"16","key":"10.1016\/j.biopha.2025.118723_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168650","article-title":"Adipose tissue: a novel target of the incretin axis? A paradigm shift in obesity-linked insulin resistance","volume":"25","author":"De Fano","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118723_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.615978","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2025.118723_bib130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fendo.2020.00178","article-title":"GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials","volume":"11","author":"Gilbert","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00228-023-03506-3","article-title":"Alogliptin: a DPP-4 inhibitor modulating adipose tissue insulin resistance and atherogenic lipid","volume":"79","author":"Kutoh","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib132","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4093\/jkd.2024.25.2.76","article-title":"GLP-1\/GIP receptor agonists: mechanism of action of tirzepatide","volume":"25","author":"Oh","year":"2024","journal-title":"J. Korean Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib133","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib134","doi-asserted-by":"crossref","first-page":"213","DOI":"10.12997\/jla.2023.12.3.213","article-title":"The cardiovascular effect of tirzepatide: a glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide dual agonist","volume":"12","author":"Cho","year":"2023","journal-title":"J. Lipid Atheroscler."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib135","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/MS9.0000000000001782","article-title":"Tirzepatide, a dual incretin analog, is a boon in metabolic syndrome: an editorial","volume":"86","author":"Bardhan","year":"2024","journal-title":"Ann. Med Surg."},{"key":"10.1016\/j.biopha.2025.118723_bib136","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/DDDT.S358989","article-title":"Designing a dual GLP-1R\/GIPR agonist from tirzepatide: comparing residues between tirzepatide, GLP-1, and GIP","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib137","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and Molecular Mechanisms of Metformin Action","volume":"42","author":"LaMoia","year":"2020","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052596","article-title":"Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history","volume":"22","author":"Kaneto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060873","article-title":"Metformin targets Foxo1 to control glucose homeostasis","volume":"11","author":"Guo","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11020087","article-title":"The effects of SGLT2 inhibitors on lipid metabolism","volume":"11","author":"Szekeres","year":"2021","journal-title":"Metabolites"},{"issue":"12","key":"10.1016\/j.biopha.2025.118723_bib141","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib142","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/a-2007-1893","article-title":"Regulation of adipose tissue insulin resistance and diabetic parameters in drug na\u00efve subjects with type 2 diabetes treated with canagliflozin monotherapy","volume":"73","author":"Kutoh","year":"2023","journal-title":"Drug Res (Stuttg. )"},{"key":"10.1016\/j.biopha.2025.118723_bib143","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/DMSO.S399367","article-title":"The neuronal and non-neuronal pathways of sodium-glucose cotransporter-2 inhibitor on body weight-loss and insulin resistance","volume":"16","author":"Dong","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib144","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00125-022-05851-x","article-title":"Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis","volume":"66","author":"Radlinger","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2025.118723_bib145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14419\/ijm.v8i1.30308","article-title":"Sodium-glucose cotransporter-2 inhibitors: current knowledge on the use of canagliflozin, dapagliflozin and empagliflozin in the treatment of type 2 diabetes mellitus","volume":"8","author":"Antoine","year":"2020","journal-title":"Int. J. Med."},{"issue":"7","key":"10.1016\/j.biopha.2025.118723_bib146","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/oby.22864","article-title":"SGLT2 inhibition, visceral adiposity, weight, and type 2 diabetes mellitus","volume":"28","author":"Carbone","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.biopha.2025.118723_bib147","article-title":"Thiazolidinediones-PPAR-\u03b3 agonists; for the treatment of type ii diabetes mellitus","volume":"45","author":"S","year":"2024","journal-title":"J. Adv. Zool."},{"key":"10.1016\/j.biopha.2025.118723_bib148","doi-asserted-by":"crossref","DOI":"10.53730\/ijhs.v6nS8.11617","article-title":"Thiazolidinediones as leads: a review","author":"Munwar","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.biopha.2025.118723_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.649018","article-title":"Efficacy of various hypoglycemic agents in the treatment of patients with nonalcoholic liver disease with or without diabetes\uff1a a network meta-analysis","volume":"12","author":"Lian","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"13","key":"10.1016\/j.biopha.2025.118723_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133220","article-title":"The mechanism of action of biguanides: new answers to a complex question","volume":"14","author":"Di Magno","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118723_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"issue":"13","key":"10.1016\/j.biopha.2025.118723_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310449","article-title":"Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials","volume":"24","author":"Popoviciu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118723_bib153","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s40618-024-02309-2","article-title":"Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study","volume":"47","author":"Bonora","year":"2024","journal-title":"J. Endocrinol. Invest"},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/life13041012","article-title":"A comprehensive review on weight loss associated with anti-diabetic medications","volume":"13","author":"Haddad","year":"2023","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc23-1791","article-title":"Occurrence of gastrointestinal adverse events upon GLP-1 receptor agonist initiation with concomitant metformin use: a post Hoc analysis of Leader, step 2, sustain-6, and pioneer 6","volume":"47","author":"Klein","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib156","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.biopha.2025.118723_bib157","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib158","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib159","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"13","key":"10.1016\/j.biopha.2025.118723_bib160","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118723_bib161","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cpdd.782","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of a liver-targeting acetyl-CoA carboxylase inhibitor (PF-05221304): a three-part randomized phase 1 study","volume":"9","author":"Bergman","year":"2020","journal-title":"Clin. Pharm. Drug Dev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030413","article-title":"Reprogramming of lipid metabolism in lung cancer: an overview with focus on EGFR-mutated non-small cell lung cancer","volume":"11","author":"Eltayeb","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2025.118723_bib163","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.117.111047","article-title":"Effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation","volume":"94","author":"Gai","year":"2018","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib164","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","article-title":"Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH","volume":"11","author":"Cariello","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030706","article-title":"Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes","volume":"9","author":"Yung","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2025.118723_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14090899","article-title":"Integrating mitochondrial biology into innovative cell therapies for neurodegenerative diseases","volume":"14","author":"Ore","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2025.118723_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.671908","article-title":"The role of mitochondrial dysfunction in vascular disease, tumorigenesis, and diabetes","volume":"8","author":"Zhunina","year":"2021","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118723_bib168","first-page":"59","article-title":"Targeting mitochondrial quality control: new therapeutic strategies for major diseases","volume":"11","author":"Hong","year":"2024","journal-title":"Mil. Med Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118723_bib169","doi-asserted-by":"crossref","DOI":"10.2174\/1573399820666230828091708","article-title":"Current state and future perspective of diabetic wound healing treatment: present evidence from clinical trials","volume":"20","author":"Dwivedi","year":"2024","journal-title":"Curr. Diabetes Rev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0041-1731460","article-title":"Updates in diabetic wound healing, inflammation, and scarring","volume":"35","author":"Dasari","year":"2021","journal-title":"Semin Plast. Surg."},{"issue":"3","key":"10.1016\/j.biopha.2025.118723_bib171","article-title":"Current approaches in healing of wounds in diabetes and diabetic foot ulcers","volume":"19","author":"Chauhan","year":"2023","journal-title":"Curr. Bioact. Compd."},{"issue":"838","key":"10.1016\/j.biopha.2025.118723_bib172","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.53738\/REVMED.2023.19.838.1486","article-title":"Revue M\u00e9dicale Suisse: Actualisation des recommandations nutritionnelles dans le traitement du diab\u00e8te de type 2","volume":"19","author":"Paquot","year":"2023","journal-title":"Rev. M\u00e9dicale Suisse"},{"key":"10.1016\/j.biopha.2025.118723_bib173","doi-asserted-by":"crossref","first-page":"54","DOI":"10.34142\/HSR.2021.07.03.04","article-title":"Correction of carbohydrate metabolism by means of physical therapy of patients with metabolic syndrome","volume":"7","author":"Kalmykova","year":"2021","journal-title":"Health Sport Rehabil."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:15:32Z","timestamp":1777014932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":173,"alternative-id":["S0753332225009175"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118723","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between hepatic lipid accumulation and type\u00a02 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118723"}}